Menu
Not yet recruiting NCT06710236

Evaluation of Investigational Hearing Instrument Features

No phase Interventional Hearing Loss

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Hearing instrument.
Who it may be relevant to
Registry conditions: Hearing Loss. Basic parameters: 18 years — 95 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this clinical trial is to learn how hearing instruments perform in varying environmental settings in adults with hearing loss. The main questions it aims to answer are: How do varying versions of hearing instrument features perform based on exposure to different environments? What is the hearing instrument user preference between varying versions of hearing instrument features? Participants will be fit with hearing instruments in the lab, and asked to wear them for the duration of the study period in their home environment. Participants will be asked to answer questionnaires throughout the study period.

Interventions

  • Device Hearing instrument
    Conventional, daily wear hearing instruments will be used in this study.

Primary outcome measures

  • Hearing instrument feature performance [Time frame: From enrollment to the completion of data collection, approximately 6 weeks]

Eligibility criteria

Inclusion criteria

  • Adult, age 18 - 95 years
  • N4 hearing loss
  • Experienced hearing aid user
  • English fluency
  • Cognitively able to complete complex listening tasks

Exclusion criteria

  • Normal hearing, or hearing loss outside the specified range
  • No hearing aid experience
  • Unable to speak, read, or write English fluently
  • Cognitive impairment
  • Any other condition or situation that impacts eligibility to participate in or complete study tasks, at the discretion of the investigator

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • Phonak Audiology Research Center — Aurora

Identifiers

NCT: NCT06710236 · SRF-26463

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗